Tag: Ann Falsey
Remdesivir results ‘promising’ in Medical Center clinical trial
The Medical Center’s Ann Falsey and Angela Branche, both with the Vaccine and Treatment and Evaluation Unit, are leading an NIH-sponsored clinical trial of remdesivir in the treatment of COVID-19.
New URMC coronavirus research examines immune response
Researchers at the University of Rochester’s New York Influenza Center of Excellence, one of five such centers of excellence in the world, are launching a new study to determine if and when a person could be re-infected with the novel coronavirus and whether some people have pre-existing immunity.
Clinical trial begins for new COVID-19 treatment
Researchers at the University of Rochester Medical Center are evaluating whether an antiviral drug is effective and safe as a treatment for hospitalized adults diagnosed with COVID-19.
Exposure to Snot-Nosed Kids Ups Severity of Cold Infections
Of people who come down with colds, the course of the infection is much more likely to be worse in people exposed to children.